Biotechnology
Medical
Pharmaceutical

Rigel Pharmaceuticals

10,293

$1.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.70%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell RIGL and other stocks, options, ETFs, and crypto commission-free!

About RIGL

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. Read More The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

CEO
Raul R. Rodriguez
Employees
163
Headquarters
South San Francisco, California
Founded
1996
Market Cap
237.68M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.17M
High Today
$1.47
Low Today
$1.36
Open Price
$1.43
Volume
931.67K
52 Week High
$3.10
52 Week Low
$1.23

Collections

Biotechnology
Medical
Pharmaceutical
Therapy
Health
Technology

RIGL Earnings

-$0.15
-$0.09
-$0.03
$0.03
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours

People Also Bought

Viking Therapeutics

51,598

$4.31

-4.01%

Viking Therapeutics

51,598

$4.31

-4.01%

Inovio

221,248

$7.45

-0.93%

Verastem

16,620

$2.52

-2.70%

Corbus Pharmaceuticals

54,206

$4.89

0.00%

You May Also Like

ALDX
GTN
USD
CHA
BF.B
DOGZ
COIHY
RTM
VNRX
BMY
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy RIGL

Market Price$1.44
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell RIGL stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up